Bavituximab: all 25 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular CarcinomaTerminatedNCT05249569Phase 2Results posted
- 1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and NeckActive, not recruitingNCT04150900Phase 2Results posted
- An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer PatientsCompletedNCT04099641Phase 2Results posted
- A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular CarcinomaCompletedNCT03519997Phase 2Results posted
- Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed GlioblastomaCompletedNCT03139916Phase 2Results posted
- Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate CancerTerminatedNCT01335204Phase 1/2Results posted
- Study of Bavituximab and Sorafenib In Patients With Advanced Liver CancerCompletedNCT01264705Phase 1/2Results posted
- Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular CarcinomaWithdrawnNCT02989870Phase 1
- A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast CancerWithdrawnNCT02685306Phase 2
- Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung CancerWithdrawnNCT02673814Phase 2
- Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast CancerWithdrawnNCT02651610Phase 2/3
- Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung CancerCompletedNCT01999673Phase 3
- A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal AdenocarcinomaCompletedNCT01634685Phase 1
- Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) SubjectsCompletedNCT01323062Phase 1
- Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast CancerCompletedNCT01288261Phase 1
- Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 InfectionCompletedNCT01273948Phase 1/2
- Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic CancerCompletedNCT01272791Phase 2
- Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung CancerCompletedNCT01160601Phase 2
- Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung CancerCompletedNCT00687817Phase 2
- A Safety and Efficacy Study of Bavituximab Plus Docetaxel in Patients With Advanced Breast CancerCompletedNCT00669591Phase 2
- Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast CancerCompletedNCT00669565Phase 2
- Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency VirusCompletedNCT00503347Phase 1
- Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis CCompletedNCT00343525Phase 1
- Study of Bavituximab in Patients With Advanced Solid Tumor MalignanciesCompletedNCT00129337Phase 1
- Study of Bavituximab in Patients With Chronic Hepatitis C Virus InfectionCompletedNCT00128271Phase 1